Allspring Global Investments Holdings, LLC Seres Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.2 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023
SELL
$4.67 - $6.55 $9,260 - $12,988
-1,983 Reduced 99.95%
1 $0
Q1 2023

Apr 13, 2023
SELL
$4.95 - $6.09 $24,037 - $29,573
-4,856 Reduced 70.99%
1,984 $11,000
Q4 2022

Jan 23, 2023
SELL
$5.09 - $9.05 $763 - $1,357
-150 Reduced 2.15%
6,840 $38.3 Million
Q2 2022

Jul 25, 2022
SELL
$2.7 - $7.62 $961 - $2,712
-356 Reduced 4.85%
6,990 $23,000
Q1 2022

May 02, 2022
BUY
$6.3 - $8.84 $46,279 - $64,938
7,346 New
7,346 $52,000

Others Institutions Holding MCRB

# of Institutions
100
Shares Held
62.7M
Call Options Held
36.9K
Put Options Held
476K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email